Thomas E. Mürdter

Statistics

Publications

Citations

4.1K

H-Index

Active since

1996

Affiliations

Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology(Current)

University of Tübingen

Robert Bosch Hospital

Heidelberg University

Saarland University

Thomas E. Mürdter is an author at Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology specializing in pharmacology, medicine, and oncology.

ORCID

Publications per year

1996–2023

Publications

Intraperitoneal Chemotherapy of Peritoneal Carcinomatosis Using Pressurized Aerosol as an Alternative to Liquid Solution: First Evidence for Efficacy

Reinhold Kerb, Thomas E. Mürdter, Urs Giger-Pabst et al. · Annals of Surgical Oncology · 2013 · 378 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Potent Mechanism-Based Inhibition of Human CYP2B6 by Clopidogrel and Ticlopidine

Tanja Richter, Thomas E. Mürdter, Georg Heinkele et al. · Journal of Pharmacology and Experimental Therapeutics · 2004 · 260 citations

Medicine, Pharmacokinetics, Pharmacology +17

Fate of the Antibiotic Sulfamethoxazole and Its Two Major Human Metabolites in a Water Sediment Test

Michael Radke, Christoph Lauwigi, Georg Heinkele et al. · Environmental Science & Technology · 2009 · 224 citations

Natural Sciences, Environmental Sciences, Toxicology +13

Tamoxifen metabolism predicts drug concentrations and outcome in premenopausal patients with early breast cancer

Pilar H. Saladores, Thomas E. Mürdter, Diana Eccles et al. · The Pharmacogenomics Journal · 2014 · 198 citations · Full text

Medicine, Oncology, Pharmacology +17

P‐glycoprotein‐mediated intestinal and biliary digoxin transport in humans

Siegfried Drescher, Hartmut Glaeser, Thomas E. Mürdter et al. · Clinical Pharmacology & Therapeutics · 2003 · 159 citations

Medicine, Pharmacokinetics, Pharmacology +16

1–5 of 81